Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290991917> ?p ?o ?g. }
- W4290991917 endingPage "2693" @default.
- W4290991917 startingPage "2683" @default.
- W4290991917 abstract "To evaluate the prostate cancer therapy efficiency of the synergistic combination docetaxel (DTX) and formononetin (FMN) in one nano-sized drug delivery system. Hyaluronic acid (HA) and epidermal growth factor receptor-targeted peptide (GE11) dual ligands were applied to modify the nano-systems.In this study, GE11-modified nanoparticles (GE-NPs) were applied for the loading of DTX, and HA-decorated NPs (HA-NPs) were used to encapsulate FMN. HA and GE11 dual ligand-modified binary nanoparticles (HAGE-DTX/FMN-NPs) were constructed by the self-assembling of GE-NPs and HA-NPs. The anti-PCa ability of the system was evaluated in vitro on PC-3 human prostate carcinoma cells (PC3 cells) and in vivo on PC3 tumor-bearing mice in comparison with single NPs and free drugs formulations.HA/GE-DTX/FMN-NPs were nano-sized particles with smaller particles coating on the inner core and achieved a size of 189.5 nm. HA/GE-DTX/FMN-NPs showed a cellular uptake efficiency of 59.6%, and a more efficient inhibition effect on PC3 cells compared with single ligand-modified NPs and free drugs. HA/GE-DTX/FMN-NPs showed significantly higher tumor inhibition efficiency than their single drug-loaded counterparts and free drugs.HA/GE-DTX/FMN-NPs have a synergistic anti-tumor effect and also could the reduce unexpected side effects during the cancer therapy. It could be used as a promising anti-PCa system." @default.
- W4290991917 created "2022-08-13" @default.
- W4290991917 creator A5004983972 @default.
- W4290991917 creator A5008526650 @default.
- W4290991917 creator A5015924872 @default.
- W4290991917 creator A5024200175 @default.
- W4290991917 creator A5040436424 @default.
- W4290991917 creator A5046406361 @default.
- W4290991917 creator A5090814462 @default.
- W4290991917 date "2022-08-01" @default.
- W4290991917 modified "2023-09-27" @default.
- W4290991917 title "Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity" @default.
- W4290991917 cites W1684168371 @default.
- W4290991917 cites W1974629843 @default.
- W4290991917 cites W1979022468 @default.
- W4290991917 cites W1979569154 @default.
- W4290991917 cites W1990591974 @default.
- W4290991917 cites W2018614342 @default.
- W4290991917 cites W2022490348 @default.
- W4290991917 cites W2024539527 @default.
- W4290991917 cites W2042362670 @default.
- W4290991917 cites W2066791556 @default.
- W4290991917 cites W2080439368 @default.
- W4290991917 cites W2090699031 @default.
- W4290991917 cites W2097465642 @default.
- W4290991917 cites W2152073639 @default.
- W4290991917 cites W2153210938 @default.
- W4290991917 cites W2157632611 @default.
- W4290991917 cites W2159048270 @default.
- W4290991917 cites W2165542862 @default.
- W4290991917 cites W2346297396 @default.
- W4290991917 cites W2566842066 @default.
- W4290991917 cites W2580617289 @default.
- W4290991917 cites W2590373381 @default.
- W4290991917 cites W2753323833 @default.
- W4290991917 cites W2775417218 @default.
- W4290991917 cites W2789624368 @default.
- W4290991917 cites W2796370042 @default.
- W4290991917 cites W2803867814 @default.
- W4290991917 cites W2806859979 @default.
- W4290991917 cites W2889646458 @default.
- W4290991917 cites W2915910399 @default.
- W4290991917 cites W2943048707 @default.
- W4290991917 cites W2971433647 @default.
- W4290991917 cites W2976837677 @default.
- W4290991917 cites W2994016738 @default.
- W4290991917 cites W3003487381 @default.
- W4290991917 cites W3005550992 @default.
- W4290991917 cites W3007276105 @default.
- W4290991917 cites W3034120350 @default.
- W4290991917 cites W3045925256 @default.
- W4290991917 cites W3081750446 @default.
- W4290991917 cites W3097157939 @default.
- W4290991917 cites W3109689457 @default.
- W4290991917 cites W3109871069 @default.
- W4290991917 cites W3133484905 @default.
- W4290991917 cites W3171502600 @default.
- W4290991917 cites W3194534902 @default.
- W4290991917 cites W4210511445 @default.
- W4290991917 doi "https://doi.org/10.2147/dddt.s366622" @default.
- W4290991917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35983428" @default.
- W4290991917 hasPublicationYear "2022" @default.
- W4290991917 type Work @default.
- W4290991917 citedByCount "6" @default.
- W4290991917 countsByYear W42909919172022 @default.
- W4290991917 countsByYear W42909919172023 @default.
- W4290991917 crossrefType "journal-article" @default.
- W4290991917 hasAuthorship W4290991917A5004983972 @default.
- W4290991917 hasAuthorship W4290991917A5008526650 @default.
- W4290991917 hasAuthorship W4290991917A5015924872 @default.
- W4290991917 hasAuthorship W4290991917A5024200175 @default.
- W4290991917 hasAuthorship W4290991917A5040436424 @default.
- W4290991917 hasAuthorship W4290991917A5046406361 @default.
- W4290991917 hasAuthorship W4290991917A5090814462 @default.
- W4290991917 hasBestOaLocation W42909919171 @default.
- W4290991917 hasConcept C105702510 @default.
- W4290991917 hasConcept C121608353 @default.
- W4290991917 hasConcept C12554922 @default.
- W4290991917 hasConcept C126322002 @default.
- W4290991917 hasConcept C150903083 @default.
- W4290991917 hasConcept C170493617 @default.
- W4290991917 hasConcept C185592680 @default.
- W4290991917 hasConcept C207001950 @default.
- W4290991917 hasConcept C2777529286 @default.
- W4290991917 hasConcept C2779438470 @default.
- W4290991917 hasConcept C2780306303 @default.
- W4290991917 hasConcept C2781190966 @default.
- W4290991917 hasConcept C502942594 @default.
- W4290991917 hasConcept C55493867 @default.
- W4290991917 hasConcept C71924100 @default.
- W4290991917 hasConcept C86803240 @default.
- W4290991917 hasConcept C96232424 @default.
- W4290991917 hasConcept C98274493 @default.
- W4290991917 hasConceptScore W4290991917C105702510 @default.
- W4290991917 hasConceptScore W4290991917C121608353 @default.
- W4290991917 hasConceptScore W4290991917C12554922 @default.
- W4290991917 hasConceptScore W4290991917C126322002 @default.
- W4290991917 hasConceptScore W4290991917C150903083 @default.